These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 1097636)

  • 1. Absorption, distribution, and metabolic fate of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one in rats, dogs, and humans.
    Edelson J; Douglas JF; Ludwig BJ; Schuster EB; Shahinian S
    J Pharm Sci; 1975 Aug; 64(8):1316-21. PubMed ID: 1097636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Absorption, distribution and metabolic fate of 2,3-dihydro-9H-isoxazolo-[3,2-b]quinazolin-9-one (W2429).
    Edelson J; Douglas JF; Ludwig BJ
    Arzneimittelforschung; 1977; 27(4):789-93. PubMed ID: 301392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Absorption, distribution, and metabolic fate of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one).
    Edelson J; Douglas JF; Ludwig BJ
    J Pharm Sci; 1973 Feb; 62(2):229-32. PubMed ID: 4631323
    [No Abstract]   [Full Text] [Related]  

  • 4. Comparative anti-inflammatory, analgesic, and antipyretic activities of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one and 5-chlorosalicylic acid in rats.
    Sofia RD; Diamantis W; Ludwig BJ
    J Pharm Sci; 1975 Aug; 64(8):1321-4. PubMed ID: 1151704
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The disposition of 3-methyl-2,3-dihydro-9H-isoxazolo[3,2-b]-quinazolin-9-one (W-2451).
    Kucharczyk N; Ballard F; Yang J; Myers G; Sofia RD
    Arch Int Pharmacodyn Ther; 1979 Jun; 239(2):180-94. PubMed ID: 114130
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NMR determination of enantiomers of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo(3,2-b)(1,3)benzoxazin-9-one using chiral shift reagent, tris(3-(heptafluorobutyryl)-d-camphorato)europium(III).
    Reisberg P; Brenner IA; Bodin JI
    J Pharm Sci; 1976 Apr; 65(4):592-4. PubMed ID: 1271263
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The in vivo antibradykinin activity of seclazone (7-chloro-3,3a-dihydro-2H,9H-isoxazolo(3,2-b) (1,3)benzoxazin-9-one), a new anti-inflammatory agent.
    Hrdina PD; Ling GM
    Pharmacology; 1973; 10(3):136-42. PubMed ID: 4761775
    [No Abstract]   [Full Text] [Related]  

  • 8. Synthesis and anti-inflammatory activity of 3,3a-dihydro-2H,9H-isoxazolo [3,2-b] [1,3]benzoxazin-9-ones and related compounds.
    Reisner DB; Ludwig BJ; Stiefel FJ; Gister S; Meyer M; Powell LS; Sofia RD
    Arzneimittelforschung; 1977; 27(4):760-6. PubMed ID: 301390
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacological properties of seclazone (7-chloro-3,3a-dihydro-2H, 9H-isoxazolo (3,2-b) (1,3) benzoxazin-9-one) a new anti-inflammatory agent.
    Berger FM; Bates HM; Diamantis W; Kletzkin M; Plekss OJ; Sofia RD; Spencer HJ
    Pharmacology; 1973; 9(3):164-76. PubMed ID: 4714232
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacology of a new non-steroidal anti-inflammatory agent 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo-(3,2-b)(1,3)-benzoxazin-9-one (W-2395).
    Sofia RD; Diamantis W; Gordon R; Kletzkin M; Berger FM; Edelson J; Singer H; Douglas JF
    Eur J Pharmacol; 1974 Apr; 26(1):51-62. PubMed ID: 4545529
    [No Abstract]   [Full Text] [Related]  

  • 11. Absorption, distribution and excretion of 3-(sulfamoyl[14C]methyl)-1,2-benziosoxazole (AD-810) in Rats, Dogs and Monkeys and of AD-810 in Men.
    Matsumoto K; Miyazaki H; Fujii T; Kagemoto A; Maeda T; Hashimoto M
    Arzneimittelforschung; 1983; 33(7):961-8. PubMed ID: 6138046
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NMR assay of diastereoisomers of 7-chloro-3,3a-dihydro-2-methyl-2H,9H-isoxazolo(3,2-b)(1,3) benzoxazin-9-one using deuterated tris(1,1,1,2,2,3,3-heptafluoro-7,7-dimethyl-4,6-octanedionato)europium III shift reagent.
    Reisberg P; Brenner IA; Bodin JI
    J Pharm Sci; 1974 Oct; 63(10):1586-91. PubMed ID: 4436793
    [No Abstract]   [Full Text] [Related]  

  • 13. Seclazone: biotransformation during absorption in the rat, binding in plasma, and disappearance from plasma in the dog.
    Edelson J; Douglas JF; Ludwig BJ
    Drug Metab Dispos; 1973; 1(6):737-41. PubMed ID: 4156294
    [No Abstract]   [Full Text] [Related]  

  • 14. Absorption, distribution and excretion of [carbonyl-14C]mosapride citrate after a single oral administration in rats, dogs and monkeys.
    Matsumoto S; Tagawa M; Amejima H; Nakao M; Kagemoto A; Fujii T; Miyazaki H; Sekine Y
    Arzneimittelforschung; 1993 Oct; 43(10):1084-94. PubMed ID: 8267675
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 2,3-Dihydro-9H-isoxazolo[3,2-b]quinazolin-9-ones and 3,4-dihydro-(1,2)-oxazino [3,2-b]quinazolin-10(2H)-ones.
    Reisner DB; Ludwig BJ; Simon E; Dejneka T; Sofia RD
    Arzneimittelforschung; 1977; 27(4):766-70. PubMed ID: 301391
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vivo absorption, distribution, excretion, and metabolism of a new herbicide, methiozolin, in rats following oral administration.
    Hwang KH; Lim JS; Kim SH; Jeon MS; Lee DG; Chung KH; Koo SJ; Kim JH
    J Agric Food Chem; 2013 Oct; 61(39):9285-92. PubMed ID: 24000999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Disposition of alpha-[(dimethylamino)methyl]-2-(3-ethyl-5-methyl-4-isoxazolyl)- 1H-indole-3-methanol (59-801), a hypoglycaemic agent in rats, dogs and monkeys.
    Tse FL; Orwig B; Jaffe JM
    Xenobiotica; 1987 Jun; 17(6):741-9. PubMed ID: 3630208
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacokinetics of NS-105, a novel cognition enhancer. 1st communication: absorption, metabolism and excretion in rats, dogs and monkeys after single administration of 14C-NS-105.
    Mukai H; Sugimoto T; Ago M; Morino A
    Arzneimittelforschung; 1999 Nov; 49(11):881-90. PubMed ID: 10604039
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Metabolism of p-(cyclopropylcarbonyl)phenylacetic acid (SQ 20,650). Species Differences.
    Lan SJ; El-Hawey AM; Dean AV; Schreiber EC
    Drug Metab Dispos; 1975; 3(3):171-9. PubMed ID: 238816
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preclinical pharmacokinetics and metabolism of 6-(4-(2,5-difluorophenyl)oxazol-5-yl)-3-isopropyl-[1,2,4]-triazolo[4,3-a]pyridine, a novel and selective p38alpha inhibitor: identification of an active metabolite in preclinical species and human liver microsomes.
    Kalgutkar AS; Hatch HL; Kosea F; Nguyen HT; Choo EF; McClure KF; Taylor TJ; Henne KR; Kuperman AV; Dombroski MA; Letavic MA
    Biopharm Drug Dispos; 2006 Nov; 27(8):371-86. PubMed ID: 16944451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.